In addition, Luo et al. found that CCL5 upregulation in bone marrow mesenchymal stem cells increased the metastatic potential of prostate cancer cells, and subsequently downregulated AR signaling, due to inhibition of AR nuclear translocation [36]. This evidence concerns the gene CCL5 and prostate carcinoma.